THC
Tenet Healthcare Corporation · Healthcare · Medical - Care Facilities
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss -4.9% · neue Nettopositionen -4.3% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 136 | +1 | 64.22M | $12.02B | +9 | −10 |
| Q1 2026 | 140 | -6 | 67.35M | $12.71B | +5 | −12 |
| Q4 2025 | 146 | 0 | 74.52M | $14.80B | +2 | −1 |
| Q3 2025 | 23 | 0 | 47.80M | $9.71B | — | −1 |
| Q2 2025 | 21 | 0 | 49.65M | $8.73B | +1 | −1 |
| Q1 2025 | 18 | +1 | 24.64M | $3.31B | +1 | — |
| Q4 2024 | 17 | -2 | 22.85M | $2.89B | — | −2 |
| Q3 2024 | 18 | 0 | 21.19M | $3.52B | — | — |
| Q2 2024 | 18 | — | 23.95M | $3.19B | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passiv) | 9.01M | -4.8% | $1.83B | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passiv) | 8.55M | -4.4% | $1.74B | 0.0% | ▼ Trim | 2 | SEC ↗ ×20 |
| 3 | Fidelity (FMR) ✦ | 7.92M | -5.6% | $1.61B | 0.1% | ▼ Trim | 2 | SEC ↗ ×6 |
| 4 | T. Rowe Price ✦ | 7.37M | +2.0% | $1.50B | 0.2% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | State Street Global Advisors ✦ (passiv) | 2.73M | -5.0% | $554.74M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Glenview Capital ✦ | 2.32M | -20.7% | $471.80M | 11.5% | ▼ Trim | 6 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 1.88M | +62.3% | $380.99M | 0.2% | ▲ Add | 6 | SEC ↗ ×6 |
| 8 | Geode Capital Management ✦ (passiv) | 1.78M | -17.6% | $361.06M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 9 | Citadel Advisors ✦ | 1.06M | -42.2% | $214.35M | 0.2% | ▼ Trim | 6 | SEC ↗ ×2 |
| 10 | JPMorgan Chase ✦ | 824.05K | — | $167.32M | 0.0% | n/c | 1 | SEC ↗ ×20 |
| 11 | Morgan Stanley ✦ | 794.89K | — | $161.40M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 12 | D. E. Shaw & Co. ✦ | 744.90K | -7.8% | $151.24M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 13 | Millennium Management ✦ | 744.35K | -26.2% | $151.13M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 473.83K | +314.4% | $96.21M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 15 | Marshall Wace ✦ | 444.56K | +1.3% | $90.26M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 16 | Adage Capital Partners ✦ | 395.51K | +10.8% | $80.31M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 372.00K | -36.0% | $75.53M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | Goldman Sachs Group ✦ | 175.32K | — | $35.60M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 19 | Wellington Management ✦ | 93.54K | +41.6% | $18.99M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 20 | Two Sigma Investments ✦ | 66.57K | +222.9% | $13.52M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 32.17K | +64.2% | $6.53M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 29.99K | -65.6% | $6.09M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 23 | Harris Associates (Oakmark) ✦ | 2.40K | 0.0% | $487,296 | 0.0% | Held | 6 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Norges Bank | $206.98M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 686 Inhaber, 81.68M Anteile, $13.63B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Käufe auf dem offenen Markt (P)
Keine Insider-Käufe auf dem offenen Markt in unserem Erfassungszeitraum.
Verkäufe auf dem offenen Markt (S)
Director · 4.03K Ant. · $1.06M
Director · 5.48K Ant. · $1.44M
Director · 2.50K Ant. · $662,079
Director · 10.00K Ant. · $2.63M
Officer · 24.00K Ant. · $6.39M
Officer, Director · 7.90K Ant. · $2.17M
Officer, Director · 17.22K Ant. · $4.71M
Officer, Director · 24.88K Ant. · $6.82M
Officer, Director · 36.66K Ant. · $10.22M
Officer, Director · 13.34K Ant. · $3.71M
Zuteilungen, Ausübungen und Steuereinbehalte werden hier nie als Käufe oder Verkäufe gezählt. Methodik